The GSK cancer drug Jemperli eradicated colon tumors in 76% of patients, a new study shows.
The GSK cancer drug Jemperli eradicated colon tumors in 76% of patients, a new study shows.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in